VEGA Steroid-Eluting Endocardial Leads (VEGA R45, VEGA R52, and VEGA R58)
MicroPort CRM S.r.l. · Decision date Jan 15, 2026
What did the FDA decide?
FDA records P130010/S005 as a supplement to PMA P130010, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 15, 2026.
FDA approval order statement
manufacturing process improvements for welding of pacing leads
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Jan 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P130010/S005
- Regulatory pathway
- PMA supplement
- Applicant
- MicroPort CRM S.r.l.
- Product code
- NVN
- Decision code
- OK30
- Decision date
- Jan 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Applicant
- MicroPort CRM S.r.l.
- Product code
- NVN
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P130010/S004 · Related supplement
VEGA R45; VEGA R52; VEGA R58; VEGA R45 RE-INTERVENTION KIT; VEGA R58 RE-INTERVENTION KIT; VEGA R45 RE-INTERVENTION KIT
P130010/S002 · Related supplement
ENERGYA/TALENTIA ICDs & CRT-Ds, SmartTouch Programmer Software Modules, SmartView Connect App, & RMS
P130010/S005 received
Application receipt date recorded by FDA.
P130010/S005 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P130010. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P130010
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| MicroPort CRM S.r.l. | PMA supplement | Jul 23, 2025 | FDA | |
| MicroPort CRM S.r.l. | PMA supplement | Nov 25, 2025 | FDA |
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC SELECTSECURE LEAD MODEL 3830P030036/S162 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 16, 2026 | FDA |
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
SelectSecure Lead 3830P030036/S161 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Aug 5, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA | |
IsoFlex LeadsP960030/S085 | ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
MicroPort CRM S.r.l.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Via Crescentino S.N., Saluggia, 13040
Sources and methodology
- Original FDA record: P130010/S005
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



